So you had surgery and were thought to have a GBM. You underwent standard of care chemoradiotherapy and your first post radiation scan looked good (so kudos to your surgeon and oncologists).
In the trial, patients underwent informed consent for surgery and tissue collection, then for leukapheresis and then enrolled and began vaccine only if : 1) the vaccine could be made, 2) no sign of tumor progression on the post radiation scan, and 3) the pathology was verified (by WHO CNS 2007 third edition criteria) as GBM by that era's standard.
In addition, patient and investigators could opt out before treatment with vaccine began.
So ... there are many selection points and times people can exit the trial. Up to 5-10% of "GBMs" of that era were classified as GBM then which would not be today (Science moves on ... weird, huh?).
So I am trying to understand your claims against the company (while congratulating you on your good fortune and health).
Market Data 
Markets 
AI
